Jane Henderson is CFO at Apogee Therapeutics, Inc. (APGE). They have made 6 open-market trades across 4 companies since 2008, most recently 2026-07-24.
CIK 0001422304
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $24K since 2008, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| APGE | SELL · 10b5-1 | 2026-05-01 | 2026-05-04 | $82.04 | $164K | -0.9% | -0.6% | +58.5% |
| APGE | SELL · 10b5-1 | 2026-04-16 | 2026-04-17 | $90.00 | $180K | -11.2% | -14.7% | +45.2% |
| APGE | SELL · 10b5-1 | 2026-04-01 | 2026-04-03 | $85.01 | $170K | +6.2% | -0.7% | +58.0% |
| APGE | SELL · 10b5-1 | 2026-03-25 | 2026-03-27 | $85.00 | $170K | +10.9% | +10.8% | +70.0% |
| APGE | SELL · 10b5-1 | 2026-03-02 | 2026-03-04 | $70.22 | $140K | -0.1% | +18.0% | +10.5% |
| APGE | SELL · 10b5-1 | 2026-02-02 | 2026-02-04 | $65.81 | $132K | +7.5% | +12.8% | +28.4% |
| APGE | SELL · 10b5-1 | 2026-01-02 | 2026-01-06 | $76.14 | $609K | +3.5% | -20.4% | +7.6% |
| APGE | SELL · 10b5-1 | 2025-12-19 | 2025-12-23 | $80.00 | $120K | +0.6% | +2.7% | +1.9% |
| APGE | SELL · 10b5-1 | 2025-12-04 | 2025-12-05 | $75.00 | $113K | -0.7% | +2.0% | -6.7% |
| APGE | SELL · 10b5-1 | 2025-11-25 | 2025-11-28 | $70.00 | $105K | +5.7% | +6.1% | -4.0% |
| APGE | SELL · 10b5-1 | 2025-11-14 | 2025-11-14 | $65.00 | $130K | +7.9% | +17.7% | +6.2% |
| APGE | SELL · 10b5-1 | 2025-11-11 | 2025-11-13 | $60.00 | $60K | +16.0% | +25.6% | +7.6% |
| AKRO | SELL | 2025-08-12 | 2025-08-12 | $47.46 | $142K | +2.4% | -6.5% | +12.6% |
| APGE | SELL | 2024-08-23 | 2024-08-23 | $48.26 | $290K | -0.3% | +19.2% | -11.4% |
| AKRO | SELL | 2023-06-16 | 2023-06-21 | $54.17 | $4.3M | -14.8% | -16.4% | -1.8% |
| VYGR | SELL | 2018-03-22 | 2018-03-26 | $20.87 | $649K | -13.3% | -10.9% | +17.1% |
| VYGR | SELL | 2018-03-16 | 2018-03-20 | $22.13 | $724K | -11.7% | -13.2% | +4.2% |
| PANC | BUY | 2008-04-30 | 2008-05-05 | $0.47 | $24K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.